Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Columbia University, New York
Women with heart attacks benefit from stenting
April 26th, 2005
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a new study reported in the April 6, 2005, issue of Circulation: Journal of the American Heart Association. A new analysis of the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial examined gender differences in outcomes after treatment with angioplasty compared to stenting, with and without the antiplatelet agent abciximab, when women and men arrive at the hospital after a heart attack. The trial investigated the safety and efficacy of stents compared to angioplasty...
Source: Cardiovascular Business Week (2005-04-26)
|
